Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
Gespeichert in:
| Veröffentlicht in: | Journal of the International AIDS Society 2010-11, Vol.13 (S4), p.O51-O51 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | O51 |
|---|---|
| container_issue | S4 |
| container_start_page | O51 |
| container_title | Journal of the International AIDS Society |
| container_volume | 13 |
| creator | Eron, J Livrozet, JM Morlat, P Lazzarin, A Katlama, C Hawkins, T Fujiwara, T Cuffe, R Vavro, C Santiago, J Ait‐Khaled, M Min, S Yeo, JM |
| description | 7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK |
| doi_str_mv | 10.1186/1758-2652-13-S4-O51 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3112867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A723607030</galeid><sourcerecordid>A723607030</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4641-135b4b94aaf40b3e9e7f3ef95a48f4ad6aded8b6f4dedf8ed80ccd4990201123</originalsourceid><addsrcrecordid>eNqNks9u1DAQxiMEEqXwBFwsIfHnEGrHjpNwQFpVdLu0ooeterWcZLxxydrFdnbZN-FxcXZXpYuoxMmj8e_7ZjzjJHlN8EdCSn5CirxMM55nKaHpnKVXOXmSHN1nnz6InycvvL_FmGclq46SX5Mm6JUOG2QVCh0gbQIsnPRj1OlaB-vQ_GQ6vyCUVXmRxTTyQ30LTfBorUOHzmc3CH5uWW0WyMl-67DSDjnw2gdpGviE1gDfUcbG3NBH7b7ezexi9m2KfBjaDXofQ0KyipMPL5NnSvYeXu3P4-T67Mv16Xl6eTWdnU4u05pxRuJ785rVFZNSMVxTqKBQFFSVS1YqJlsuW2jLmisWT1XGGDdNy6oKZzhWosfJ553t3VAvoW3AhPgAcef0UrqNsFKLwxujO7GwK0GjuuRFNDjbGdTaPmJweNPYpRi3IcZtCELFnIm4r2j0bt-Jsz8G8EEstW-g76UBO3hRlhSPEhrJN3-Rt3ZwJk5JUMwLTvK43T_UQvYgtFE2lm9GTzEpMspxgSmOVPoPagEGYq_WgNIxfcC_fcB3EJfdedsPQVvjD0G6AxtnvXeg7kdCsBg_7SNDqHaqday7-R-J-DqbZFvtb6aU7yU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3067615062</pqid></control><display><type>article</type><title>Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)</title><source>Wiley Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Springer Nature OA Free Journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Eron, J ; Livrozet, JM ; Morlat, P ; Lazzarin, A ; Katlama, C ; Hawkins, T ; Fujiwara, T ; Cuffe, R ; Vavro, C ; Santiago, J ; Ait‐Khaled, M ; Min, S ; Yeo, JM</creator><creatorcontrib>Eron, J ; Livrozet, JM ; Morlat, P ; Lazzarin, A ; Katlama, C ; Hawkins, T ; Fujiwara, T ; Cuffe, R ; Vavro, C ; Santiago, J ; Ait‐Khaled, M ; Min, S ; Yeo, JM</creatorcontrib><description>7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK</description><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.1186/1758-2652-13-S4-O51</identifier><language>eng</language><publisher>Geneva: The International AIDS Society</publisher><subject>Analysis ; Antiviral agents ; Disease susceptibility ; Dosage and administration ; HIV infection ; HIV testing ; Human immunodeficiency virus ; Integrase inhibitors ; Oral Presentation ; Prevention ; Risk factors ; Testing</subject><ispartof>Journal of the International AIDS Society, 2010-11, Vol.13 (S4), p.O51-O51</ispartof><rights>2010 Eron J et al; licensee International AIDS Society</rights><rights>COPYRIGHT 2010 John Wiley & Sons, Inc.</rights><rights>2010. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright ©2010 Min et al; licensee BioMed Central Ltd. 2010 Min et al; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b4641-135b4b94aaf40b3e9e7f3ef95a48f4ad6aded8b6f4dedf8ed80ccd4990201123</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112867/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112867/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids></links><search><creatorcontrib>Eron, J</creatorcontrib><creatorcontrib>Livrozet, JM</creatorcontrib><creatorcontrib>Morlat, P</creatorcontrib><creatorcontrib>Lazzarin, A</creatorcontrib><creatorcontrib>Katlama, C</creatorcontrib><creatorcontrib>Hawkins, T</creatorcontrib><creatorcontrib>Fujiwara, T</creatorcontrib><creatorcontrib>Cuffe, R</creatorcontrib><creatorcontrib>Vavro, C</creatorcontrib><creatorcontrib>Santiago, J</creatorcontrib><creatorcontrib>Ait‐Khaled, M</creatorcontrib><creatorcontrib>Min, S</creatorcontrib><creatorcontrib>Yeo, JM</creatorcontrib><title>Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)</title><title>Journal of the International AIDS Society</title><description>7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK</description><subject>Analysis</subject><subject>Antiviral agents</subject><subject>Disease susceptibility</subject><subject>Dosage and administration</subject><subject>HIV infection</subject><subject>HIV testing</subject><subject>Human immunodeficiency virus</subject><subject>Integrase inhibitors</subject><subject>Oral Presentation</subject><subject>Prevention</subject><subject>Risk factors</subject><subject>Testing</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNqNks9u1DAQxiMEEqXwBFwsIfHnEGrHjpNwQFpVdLu0ooeterWcZLxxydrFdnbZN-FxcXZXpYuoxMmj8e_7ZjzjJHlN8EdCSn5CirxMM55nKaHpnKVXOXmSHN1nnz6InycvvL_FmGclq46SX5Mm6JUOG2QVCh0gbQIsnPRj1OlaB-vQ_GQ6vyCUVXmRxTTyQ30LTfBorUOHzmc3CH5uWW0WyMl-67DSDjnw2gdpGviE1gDfUcbG3NBH7b7ezexi9m2KfBjaDXofQ0KyipMPL5NnSvYeXu3P4-T67Mv16Xl6eTWdnU4u05pxRuJ785rVFZNSMVxTqKBQFFSVS1YqJlsuW2jLmisWT1XGGDdNy6oKZzhWosfJ553t3VAvoW3AhPgAcef0UrqNsFKLwxujO7GwK0GjuuRFNDjbGdTaPmJweNPYpRi3IcZtCELFnIm4r2j0bt-Jsz8G8EEstW-g76UBO3hRlhSPEhrJN3-Rt3ZwJk5JUMwLTvK43T_UQvYgtFE2lm9GTzEpMspxgSmOVPoPagEGYq_WgNIxfcC_fcB3EJfdedsPQVvjD0G6AxtnvXeg7kdCsBg_7SNDqHaqday7-R-J-DqbZFvtb6aU7yU</recordid><startdate>201011</startdate><enddate>201011</enddate><creator>Eron, J</creator><creator>Livrozet, JM</creator><creator>Morlat, P</creator><creator>Lazzarin, A</creator><creator>Katlama, C</creator><creator>Hawkins, T</creator><creator>Fujiwara, T</creator><creator>Cuffe, R</creator><creator>Vavro, C</creator><creator>Santiago, J</creator><creator>Ait‐Khaled, M</creator><creator>Min, S</creator><creator>Yeo, JM</creator><general>The International AIDS Society</general><general>John Wiley & Sons, Inc</general><general>BioMed Central Ltd</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>201011</creationdate><title>Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)</title><author>Eron, J ; Livrozet, JM ; Morlat, P ; Lazzarin, A ; Katlama, C ; Hawkins, T ; Fujiwara, T ; Cuffe, R ; Vavro, C ; Santiago, J ; Ait‐Khaled, M ; Min, S ; Yeo, JM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4641-135b4b94aaf40b3e9e7f3ef95a48f4ad6aded8b6f4dedf8ed80ccd4990201123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Analysis</topic><topic>Antiviral agents</topic><topic>Disease susceptibility</topic><topic>Dosage and administration</topic><topic>HIV infection</topic><topic>HIV testing</topic><topic>Human immunodeficiency virus</topic><topic>Integrase inhibitors</topic><topic>Oral Presentation</topic><topic>Prevention</topic><topic>Risk factors</topic><topic>Testing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eron, J</creatorcontrib><creatorcontrib>Livrozet, JM</creatorcontrib><creatorcontrib>Morlat, P</creatorcontrib><creatorcontrib>Lazzarin, A</creatorcontrib><creatorcontrib>Katlama, C</creatorcontrib><creatorcontrib>Hawkins, T</creatorcontrib><creatorcontrib>Fujiwara, T</creatorcontrib><creatorcontrib>Cuffe, R</creatorcontrib><creatorcontrib>Vavro, C</creatorcontrib><creatorcontrib>Santiago, J</creatorcontrib><creatorcontrib>Ait‐Khaled, M</creatorcontrib><creatorcontrib>Min, S</creatorcontrib><creatorcontrib>Yeo, JM</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eron, J</au><au>Livrozet, JM</au><au>Morlat, P</au><au>Lazzarin, A</au><au>Katlama, C</au><au>Hawkins, T</au><au>Fujiwara, T</au><au>Cuffe, R</au><au>Vavro, C</au><au>Santiago, J</au><au>Ait‐Khaled, M</au><au>Min, S</au><au>Yeo, JM</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)</atitle><jtitle>Journal of the International AIDS Society</jtitle><date>2010-11</date><risdate>2010</risdate><volume>13</volume><issue>S4</issue><spage>O51</spage><epage>O51</epage><pages>O51-O51</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><abstract>7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK</abstract><cop>Geneva</cop><pub>The International AIDS Society</pub><doi>10.1186/1758-2652-13-S4-O51</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1758-2652 |
| ispartof | Journal of the International AIDS Society, 2010-11, Vol.13 (S4), p.O51-O51 |
| issn | 1758-2652 1758-2652 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3112867 |
| source | Wiley Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Springer Nature OA Free Journals; Wiley Online Library (Open Access Collection); PubMed Central |
| subjects | Analysis Antiviral agents Disease susceptibility Dosage and administration HIV infection HIV testing Human immunodeficiency virus Integrase inhibitors Oral Presentation Prevention Risk factors Testing |
| title | Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T06%3A37%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activity%20of%20the%20integrase%20inhibitor%20S/GSK1349572%20in%20subjects%20with%20HIV%20exhibiting%20raltegravir%20resistance:%20week%2024%20results%20of%20the%20VIKING%20study%20(ING112961)&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Eron,%20J&rft.date=2010-11&rft.volume=13&rft.issue=S4&rft.spage=O51&rft.epage=O51&rft.pages=O51-O51&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.1186/1758-2652-13-S4-O51&rft_dat=%3Cgale_pubme%3EA723607030%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3067615062&rft_id=info:pmid/&rft_galeid=A723607030&rfr_iscdi=true |